01 September 1997
Nadroparin calcium in the treatment of acute myocardial infarction
Adam M. Curyło, Kalina Kawecka-Jaszcz, Danuta Czarnecka, Janusz Grodecki, Ryszard Drożdż, Jerzy W. NaskalskiMed Sci Monit 1997; 3(5): CR700-703 :: ID: 501623
Abstract
The present study was undertaken to define the effects of streptokinase combined with nadroparin calcium (Fraxiparine) as compared with streptokinase combined with heparin in the treatment of myocardial infarction. The study population consisted of 86 patients with acute myocardial infarction randomized into a group given streptokinase and nadroparin calcium (45 patients) and a group treated with streptokinase and heparin (41 patients). The patients were evaluated with respect to the rate of enzyme changes, electrocardiographic and echocardiographic changes, the rate of reinfarctions, rhythm disorders, hemorrhagic complications and mortality. Patients treated with nadroparin calcium showed an earlier peak activity of CK, CKMB and myoglobin concentration than controls. In the same group there were also more patients with 50% reduction of the sum of ST segment elevations after 2 hours of therapy. Both groups did not differ in the peak activity of enzymes, the frequency of left ventricular thrombus, severe arrhythmias, reinfarctions and hemorrhagic complications. Ejection fraction was insignificantly higher in those treated with nadroparin calcium and mortality in the patients given heparin.The present results seem to indicate higher frequency of myocardial reperfusion in patients treated with streptokinase and nadroparin calcium than in those treated with streptokinase and heparin.
Keywords: thrombolysis, Streptokinase, Heparin, creatine kinase
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952